Peptide Therapy Market, Global Outlook and Forecast 2022-2028
Peptide therapy refers to restoring the amount of peptides to stimulate the cellular regeneration system in the body, and can be an excellent complement to small molecule and biotherapeutics as a treatment option under certain conditions. The most common uses of peptide therapy are to help build muscle and reduce fat, increase energy, improve sexual function, and reduce gastrointestinal and musculoskeletal inflammation. The most common prescription peptide combinations naturally boost growth hormone for better recovery. Peptides were initially used only for diagnostics and hormone therapy; however, as technology has advanced, they are now also widely used to treat cancer and chronic metabolic diseases. Peptides are also used in cosmeceutical operations to slow down the skin's aging process.
This report contains market size and forecasts of Peptide Therapy in global, including the following market information:
Global Peptide Therapy Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Peptide Therapy Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Peptide Therapy companies in 2021 (%)
The global Peptide Therapy market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Parenteral Route of Administration Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Peptide Therapy include Eli Lilly, AstraZeneca, Merck, Ipsen, Novo Nordisk, Teva Pharmaceutical Industries, Abbott Laboratories, Sanofi and J & J, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Peptide Therapy manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Peptide Therapy Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Peptide Therapy Market Segment Percentages, by Type, 2021 (%)
Global Peptide Therapy Market Segment Percentages, by Application, 2021 (%)
Global Peptide Therapy Market Segment Percentages, By Region and Country, 2021 (%)
The report also provides analysis of leading market participants including:
Key companies Peptide Therapy revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Peptide Therapy revenues share in global market, 2021 (%)
Key companies Peptide Therapy sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Peptide Therapy sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
This report contains market size and forecasts of Peptide Therapy in global, including the following market information:
Global Peptide Therapy Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Peptide Therapy Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Peptide Therapy companies in 2021 (%)
The global Peptide Therapy market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Parenteral Route of Administration Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Peptide Therapy include Eli Lilly, AstraZeneca, Merck, Ipsen, Novo Nordisk, Teva Pharmaceutical Industries, Abbott Laboratories, Sanofi and J & J, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Peptide Therapy manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Peptide Therapy Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Peptide Therapy Market Segment Percentages, by Type, 2021 (%)
- Parenteral Route of Administration
- Mucosal Route of Administration
- Oral Route of Administration
- Transdermal Route of Administration
Global Peptide Therapy Market Segment Percentages, by Application, 2021 (%)
- Cancer
- Cardiovascular Diseases
- Gastrointestinal Disorders
- Metabolic Disorders
- Others
Global Peptide Therapy Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Peptide Therapy revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Peptide Therapy revenues share in global market, 2021 (%)
Key companies Peptide Therapy sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Peptide Therapy sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Eli Lilly
- AstraZeneca
- Merck
- Ipsen
- Novo Nordisk
- Teva Pharmaceutical Industries
- Abbott Laboratories
- Sanofi
- J & J
- Novartis
- Takeda
- Ferring
- AbbVie
- Heinis
- Hemmo
- Emcure Pharmaceutical
- Cipla
- Gland Pharma
- Troikaa Pharmaceuticals
- Biological E
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Peptide Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Peptide Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL PEPTIDE THERAPY OVERALL MARKET SIZE
2.1 Global Peptide Therapy Market Size: 2021 VS 2028
2.2 Global Peptide Therapy Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Peptide Therapy Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Peptide Therapy Players in Global Market
3.2 Top Global Peptide Therapy Companies Ranked by Revenue
3.3 Global Peptide Therapy Revenue by Companies
3.4 Global Peptide Therapy Sales by Companies
3.5 Global Peptide Therapy Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Peptide Therapy Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Peptide Therapy Product Type
3.8 Tier 1, Tier 2 and Tier 3 Peptide Therapy Players in Global Market
3.8.1 List of Global Tier 1 Peptide Therapy Companies
3.8.2 List of Global Tier 2 and Tier 3 Peptide Therapy Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Peptide Therapy Market Size Markets, 2021 & 2028
4.1.2 Parenteral Route of Administration
4.1.3 Mucosal Route of Administration
4.1.4 Oral Route of Administration
4.1.5 Transdermal Route of Administration
4.2 By Type - Global Peptide Therapy Revenue & Forecasts
4.2.1 By Type - Global Peptide Therapy Revenue, 2017-2022
4.2.2 By Type - Global Peptide Therapy Revenue, 2023-2028
4.2.3 By Type - Global Peptide Therapy Revenue Market Share, 2017-2028
4.3 By Type - Global Peptide Therapy Sales & Forecasts
4.3.1 By Type - Global Peptide Therapy Sales, 2017-2022
4.3.2 By Type - Global Peptide Therapy Sales, 2023-2028
4.3.3 By Type - Global Peptide Therapy Sales Market Share, 2017-2028
4.4 By Type - Global Peptide Therapy Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Peptide Therapy Market Size, 2021 & 2028
5.1.2 Cancer
5.1.3 Cardiovascular Diseases
5.1.4 Gastrointestinal Disorders
5.1.5 Metabolic Disorders
5.1.6 Others
5.2 By Application - Global Peptide Therapy Revenue & Forecasts
5.2.1 By Application - Global Peptide Therapy Revenue, 2017-2022
5.2.2 By Application - Global Peptide Therapy Revenue, 2023-2028
5.2.3 By Application - Global Peptide Therapy Revenue Market Share, 2017-2028
5.3 By Application - Global Peptide Therapy Sales & Forecasts
5.3.1 By Application - Global Peptide Therapy Sales, 2017-2022
5.3.2 By Application - Global Peptide Therapy Sales, 2023-2028
5.3.3 By Application - Global Peptide Therapy Sales Market Share, 2017-2028
5.4 By Application - Global Peptide Therapy Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Peptide Therapy Market Size, 2021 & 2028
6.2 By Region - Global Peptide Therapy Revenue & Forecasts
6.2.1 By Region - Global Peptide Therapy Revenue, 2017-2022
6.2.2 By Region - Global Peptide Therapy Revenue, 2023-2028
6.2.3 By Region - Global Peptide Therapy Revenue Market Share, 2017-2028
6.3 By Region - Global Peptide Therapy Sales & Forecasts
6.3.1 By Region - Global Peptide Therapy Sales, 2017-2022
6.3.2 By Region - Global Peptide Therapy Sales, 2023-2028
6.3.3 By Region - Global Peptide Therapy Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Peptide Therapy Revenue, 2017-2028
6.4.2 By Country - North America Peptide Therapy Sales, 2017-2028
6.4.3 US Peptide Therapy Market Size, 2017-2028
6.4.4 Canada Peptide Therapy Market Size, 2017-2028
6.4.5 Mexico Peptide Therapy Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Peptide Therapy Revenue, 2017-2028
6.5.2 By Country - Europe Peptide Therapy Sales, 2017-2028
6.5.3 Germany Peptide Therapy Market Size, 2017-2028
6.5.4 France Peptide Therapy Market Size, 2017-2028
6.5.5 U.K. Peptide Therapy Market Size, 2017-2028
6.5.6 Italy Peptide Therapy Market Size, 2017-2028
6.5.7 Russia Peptide Therapy Market Size, 2017-2028
6.5.8 Nordic Countries Peptide Therapy Market Size, 2017-2028
6.5.9 Benelux Peptide Therapy Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Peptide Therapy Revenue, 2017-2028
6.6.2 By Region - Asia Peptide Therapy Sales, 2017-2028
6.6.3 China Peptide Therapy Market Size, 2017-2028
6.6.4 Japan Peptide Therapy Market Size, 2017-2028
6.6.5 South Korea Peptide Therapy Market Size, 2017-2028
6.6.6 Southeast Asia Peptide Therapy Market Size, 2017-2028
6.6.7 India Peptide Therapy Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Peptide Therapy Revenue, 2017-2028
6.7.2 By Country - South America Peptide Therapy Sales, 2017-2028
6.7.3 Brazil Peptide Therapy Market Size, 2017-2028
6.7.4 Argentina Peptide Therapy Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Peptide Therapy Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Peptide Therapy Sales, 2017-2028
6.8.3 Turkey Peptide Therapy Market Size, 2017-2028
6.8.4 Israel Peptide Therapy Market Size, 2017-2028
6.8.5 Saudi Arabia Peptide Therapy Market Size, 2017-2028
6.8.6 UAE Peptide Therapy Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Eli Lilly
7.1.1 Eli Lilly Corporate Summary
7.1.2 Eli Lilly Business Overview
7.1.3 Eli Lilly Peptide Therapy Major Product Offerings
7.1.4 Eli Lilly Peptide Therapy Sales and Revenue in Global (2017-2022)
7.1.5 Eli Lilly Key News
7.2 AstraZeneca
7.2.1 AstraZeneca Corporate Summary
7.2.2 AstraZeneca Business Overview
7.2.3 AstraZeneca Peptide Therapy Major Product Offerings
7.2.4 AstraZeneca Peptide Therapy Sales and Revenue in Global (2017-2022)
7.2.5 AstraZeneca Key News
7.3 Merck
7.3.1 Merck Corporate Summary
7.3.2 Merck Business Overview
7.3.3 Merck Peptide Therapy Major Product Offerings
7.3.4 Merck Peptide Therapy Sales and Revenue in Global (2017-2022)
7.3.5 Merck Key News
7.4 Ipsen
7.4.1 Ipsen Corporate Summary
7.4.2 Ipsen Business Overview
7.4.3 Ipsen Peptide Therapy Major Product Offerings
7.4.4 Ipsen Peptide Therapy Sales and Revenue in Global (2017-2022)
7.4.5 Ipsen Key News
7.5 Novo Nordisk
7.5.1 Novo Nordisk Corporate Summary
7.5.2 Novo Nordisk Business Overview
7.5.3 Novo Nordisk Peptide Therapy Major Product Offerings
7.5.4 Novo Nordisk Peptide Therapy Sales and Revenue in Global (2017-2022)
7.5.5 Novo Nordisk Key News
7.6 Teva Pharmaceutical Industries
7.6.1 Teva Pharmaceutical Industries Corporate Summary
7.6.2 Teva Pharmaceutical Industries Business Overview
7.6.3 Teva Pharmaceutical Industries Peptide Therapy Major Product Offerings
7.6.4 Teva Pharmaceutical Industries Peptide Therapy Sales and Revenue in Global (2017-2022)
7.6.5 Teva Pharmaceutical Industries Key News
7.7 Abbott Laboratories
7.7.1 Abbott Laboratories Corporate Summary
7.7.2 Abbott Laboratories Business Overview
7.7.3 Abbott Laboratories Peptide Therapy Major Product Offerings
7.7.4 Abbott Laboratories Peptide Therapy Sales and Revenue in Global (2017-2022)
7.7.5 Abbott Laboratories Key News
7.8 Sanofi
7.8.1 Sanofi Corporate Summary
7.8.2 Sanofi Business Overview
7.8.3 Sanofi Peptide Therapy Major Product Offerings
7.8.4 Sanofi Peptide Therapy Sales and Revenue in Global (2017-2022)
7.8.5 Sanofi Key News
7.9 J & J
7.9.1 J & J Corporate Summary
7.9.2 J & J Business Overview
7.9.3 J & J Peptide Therapy Major Product Offerings
7.9.4 J & J Peptide Therapy Sales and Revenue in Global (2017-2022)
7.9.5 J & J Key News
7.10 Novartis
7.10.1 Novartis Corporate Summary
7.10.2 Novartis Business Overview
7.10.3 Novartis Peptide Therapy Major Product Offerings
7.10.4 Novartis Peptide Therapy Sales and Revenue in Global (2017-2022)
7.10.5 Novartis Key News
7.11 Takeda
7.11.1 Takeda Corporate Summary
7.11.2 Takeda Peptide Therapy Business Overview
7.11.3 Takeda Peptide Therapy Major Product Offerings
7.11.4 Takeda Peptide Therapy Sales and Revenue in Global (2017-2022)
7.11.5 Takeda Key News
7.12 Ferring
7.12.1 Ferring Corporate Summary
7.12.2 Ferring Peptide Therapy Business Overview
7.12.3 Ferring Peptide Therapy Major Product Offerings
7.12.4 Ferring Peptide Therapy Sales and Revenue in Global (2017-2022)
7.12.5 Ferring Key News
7.13 AbbVie
7.13.1 AbbVie Corporate Summary
7.13.2 AbbVie Peptide Therapy Business Overview
7.13.3 AbbVie Peptide Therapy Major Product Offerings
7.13.4 AbbVie Peptide Therapy Sales and Revenue in Global (2017-2022)
7.13.5 AbbVie Key News
7.14 Heinis
7.14.1 Heinis Corporate Summary
7.14.2 Heinis Business Overview
7.14.3 Heinis Peptide Therapy Major Product Offerings
7.14.4 Heinis Peptide Therapy Sales and Revenue in Global (2017-2022)
7.14.5 Heinis Key News
7.15 Hemmo
7.15.1 Hemmo Corporate Summary
7.15.2 Hemmo Business Overview
7.15.3 Hemmo Peptide Therapy Major Product Offerings
7.15.4 Hemmo Peptide Therapy Sales and Revenue in Global (2017-2022)
7.15.5 Hemmo Key News
7.16 Emcure Pharmaceutical
7.16.1 Emcure Pharmaceutical Corporate Summary
7.16.2 Emcure Pharmaceutical Business Overview
7.16.3 Emcure Pharmaceutical Peptide Therapy Major Product Offerings
7.16.4 Emcure Pharmaceutical Peptide Therapy Sales and Revenue in Global (2017-2022)
7.16.5 Emcure Pharmaceutical Key News
7.17 Cipla
7.17.1 Cipla Corporate Summary
7.17.2 Cipla Business Overview
7.17.3 Cipla Peptide Therapy Major Product Offerings
7.17.4 Cipla Peptide Therapy Sales and Revenue in Global (2017-2022)
7.17.5 Cipla Key News
7.18 Gland Pharma
7.18.1 Gland Pharma Corporate Summary
7.18.2 Gland Pharma Business Overview
7.18.3 Gland Pharma Peptide Therapy Major Product Offerings
7.18.4 Gland Pharma Peptide Therapy Sales and Revenue in Global (2017-2022)
7.18.5 Gland Pharma Key News
7.19 Troikaa Pharmaceuticals
7.19.1 Troikaa Pharmaceuticals Corporate Summary
7.19.2 Troikaa Pharmaceuticals Business Overview
7.19.3 Troikaa Pharmaceuticals Peptide Therapy Major Product Offerings
7.19.4 Troikaa Pharmaceuticals Peptide Therapy Sales and Revenue in Global (2017-2022)
7.19.5 Troikaa Pharmaceuticals Key News
7.20 Biological E
7.20.1 Biological E Corporate Summary
7.20.2 Biological E Business Overview
7.20.3 Biological E Peptide Therapy Major Product Offerings
7.20.4 Biological E Peptide Therapy Sales and Revenue in Global (2017-2022)
7.20.5 Biological E Key News
8 GLOBAL PEPTIDE THERAPY PRODUCTION CAPACITY, ANALYSIS
8.1 Global Peptide Therapy Production Capacity, 2017-2028
8.2 Peptide Therapy Production Capacity of Key Manufacturers in Global Market
8.3 Global Peptide Therapy Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 PEPTIDE THERAPY SUPPLY CHAIN ANALYSIS
10.1 Peptide Therapy Industry Value Chain
10.2 Peptide Therapy Upstream Market
10.3 Peptide Therapy Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Peptide Therapy Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
1.1 Peptide Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Peptide Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL PEPTIDE THERAPY OVERALL MARKET SIZE
2.1 Global Peptide Therapy Market Size: 2021 VS 2028
2.2 Global Peptide Therapy Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Peptide Therapy Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Peptide Therapy Players in Global Market
3.2 Top Global Peptide Therapy Companies Ranked by Revenue
3.3 Global Peptide Therapy Revenue by Companies
3.4 Global Peptide Therapy Sales by Companies
3.5 Global Peptide Therapy Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Peptide Therapy Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Peptide Therapy Product Type
3.8 Tier 1, Tier 2 and Tier 3 Peptide Therapy Players in Global Market
3.8.1 List of Global Tier 1 Peptide Therapy Companies
3.8.2 List of Global Tier 2 and Tier 3 Peptide Therapy Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Peptide Therapy Market Size Markets, 2021 & 2028
4.1.2 Parenteral Route of Administration
4.1.3 Mucosal Route of Administration
4.1.4 Oral Route of Administration
4.1.5 Transdermal Route of Administration
4.2 By Type - Global Peptide Therapy Revenue & Forecasts
4.2.1 By Type - Global Peptide Therapy Revenue, 2017-2022
4.2.2 By Type - Global Peptide Therapy Revenue, 2023-2028
4.2.3 By Type - Global Peptide Therapy Revenue Market Share, 2017-2028
4.3 By Type - Global Peptide Therapy Sales & Forecasts
4.3.1 By Type - Global Peptide Therapy Sales, 2017-2022
4.3.2 By Type - Global Peptide Therapy Sales, 2023-2028
4.3.3 By Type - Global Peptide Therapy Sales Market Share, 2017-2028
4.4 By Type - Global Peptide Therapy Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Peptide Therapy Market Size, 2021 & 2028
5.1.2 Cancer
5.1.3 Cardiovascular Diseases
5.1.4 Gastrointestinal Disorders
5.1.5 Metabolic Disorders
5.1.6 Others
5.2 By Application - Global Peptide Therapy Revenue & Forecasts
5.2.1 By Application - Global Peptide Therapy Revenue, 2017-2022
5.2.2 By Application - Global Peptide Therapy Revenue, 2023-2028
5.2.3 By Application - Global Peptide Therapy Revenue Market Share, 2017-2028
5.3 By Application - Global Peptide Therapy Sales & Forecasts
5.3.1 By Application - Global Peptide Therapy Sales, 2017-2022
5.3.2 By Application - Global Peptide Therapy Sales, 2023-2028
5.3.3 By Application - Global Peptide Therapy Sales Market Share, 2017-2028
5.4 By Application - Global Peptide Therapy Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Peptide Therapy Market Size, 2021 & 2028
6.2 By Region - Global Peptide Therapy Revenue & Forecasts
6.2.1 By Region - Global Peptide Therapy Revenue, 2017-2022
6.2.2 By Region - Global Peptide Therapy Revenue, 2023-2028
6.2.3 By Region - Global Peptide Therapy Revenue Market Share, 2017-2028
6.3 By Region - Global Peptide Therapy Sales & Forecasts
6.3.1 By Region - Global Peptide Therapy Sales, 2017-2022
6.3.2 By Region - Global Peptide Therapy Sales, 2023-2028
6.3.3 By Region - Global Peptide Therapy Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Peptide Therapy Revenue, 2017-2028
6.4.2 By Country - North America Peptide Therapy Sales, 2017-2028
6.4.3 US Peptide Therapy Market Size, 2017-2028
6.4.4 Canada Peptide Therapy Market Size, 2017-2028
6.4.5 Mexico Peptide Therapy Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Peptide Therapy Revenue, 2017-2028
6.5.2 By Country - Europe Peptide Therapy Sales, 2017-2028
6.5.3 Germany Peptide Therapy Market Size, 2017-2028
6.5.4 France Peptide Therapy Market Size, 2017-2028
6.5.5 U.K. Peptide Therapy Market Size, 2017-2028
6.5.6 Italy Peptide Therapy Market Size, 2017-2028
6.5.7 Russia Peptide Therapy Market Size, 2017-2028
6.5.8 Nordic Countries Peptide Therapy Market Size, 2017-2028
6.5.9 Benelux Peptide Therapy Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Peptide Therapy Revenue, 2017-2028
6.6.2 By Region - Asia Peptide Therapy Sales, 2017-2028
6.6.3 China Peptide Therapy Market Size, 2017-2028
6.6.4 Japan Peptide Therapy Market Size, 2017-2028
6.6.5 South Korea Peptide Therapy Market Size, 2017-2028
6.6.6 Southeast Asia Peptide Therapy Market Size, 2017-2028
6.6.7 India Peptide Therapy Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Peptide Therapy Revenue, 2017-2028
6.7.2 By Country - South America Peptide Therapy Sales, 2017-2028
6.7.3 Brazil Peptide Therapy Market Size, 2017-2028
6.7.4 Argentina Peptide Therapy Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Peptide Therapy Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Peptide Therapy Sales, 2017-2028
6.8.3 Turkey Peptide Therapy Market Size, 2017-2028
6.8.4 Israel Peptide Therapy Market Size, 2017-2028
6.8.5 Saudi Arabia Peptide Therapy Market Size, 2017-2028
6.8.6 UAE Peptide Therapy Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Eli Lilly
7.1.1 Eli Lilly Corporate Summary
7.1.2 Eli Lilly Business Overview
7.1.3 Eli Lilly Peptide Therapy Major Product Offerings
7.1.4 Eli Lilly Peptide Therapy Sales and Revenue in Global (2017-2022)
7.1.5 Eli Lilly Key News
7.2 AstraZeneca
7.2.1 AstraZeneca Corporate Summary
7.2.2 AstraZeneca Business Overview
7.2.3 AstraZeneca Peptide Therapy Major Product Offerings
7.2.4 AstraZeneca Peptide Therapy Sales and Revenue in Global (2017-2022)
7.2.5 AstraZeneca Key News
7.3 Merck
7.3.1 Merck Corporate Summary
7.3.2 Merck Business Overview
7.3.3 Merck Peptide Therapy Major Product Offerings
7.3.4 Merck Peptide Therapy Sales and Revenue in Global (2017-2022)
7.3.5 Merck Key News
7.4 Ipsen
7.4.1 Ipsen Corporate Summary
7.4.2 Ipsen Business Overview
7.4.3 Ipsen Peptide Therapy Major Product Offerings
7.4.4 Ipsen Peptide Therapy Sales and Revenue in Global (2017-2022)
7.4.5 Ipsen Key News
7.5 Novo Nordisk
7.5.1 Novo Nordisk Corporate Summary
7.5.2 Novo Nordisk Business Overview
7.5.3 Novo Nordisk Peptide Therapy Major Product Offerings
7.5.4 Novo Nordisk Peptide Therapy Sales and Revenue in Global (2017-2022)
7.5.5 Novo Nordisk Key News
7.6 Teva Pharmaceutical Industries
7.6.1 Teva Pharmaceutical Industries Corporate Summary
7.6.2 Teva Pharmaceutical Industries Business Overview
7.6.3 Teva Pharmaceutical Industries Peptide Therapy Major Product Offerings
7.6.4 Teva Pharmaceutical Industries Peptide Therapy Sales and Revenue in Global (2017-2022)
7.6.5 Teva Pharmaceutical Industries Key News
7.7 Abbott Laboratories
7.7.1 Abbott Laboratories Corporate Summary
7.7.2 Abbott Laboratories Business Overview
7.7.3 Abbott Laboratories Peptide Therapy Major Product Offerings
7.7.4 Abbott Laboratories Peptide Therapy Sales and Revenue in Global (2017-2022)
7.7.5 Abbott Laboratories Key News
7.8 Sanofi
7.8.1 Sanofi Corporate Summary
7.8.2 Sanofi Business Overview
7.8.3 Sanofi Peptide Therapy Major Product Offerings
7.8.4 Sanofi Peptide Therapy Sales and Revenue in Global (2017-2022)
7.8.5 Sanofi Key News
7.9 J & J
7.9.1 J & J Corporate Summary
7.9.2 J & J Business Overview
7.9.3 J & J Peptide Therapy Major Product Offerings
7.9.4 J & J Peptide Therapy Sales and Revenue in Global (2017-2022)
7.9.5 J & J Key News
7.10 Novartis
7.10.1 Novartis Corporate Summary
7.10.2 Novartis Business Overview
7.10.3 Novartis Peptide Therapy Major Product Offerings
7.10.4 Novartis Peptide Therapy Sales and Revenue in Global (2017-2022)
7.10.5 Novartis Key News
7.11 Takeda
7.11.1 Takeda Corporate Summary
7.11.2 Takeda Peptide Therapy Business Overview
7.11.3 Takeda Peptide Therapy Major Product Offerings
7.11.4 Takeda Peptide Therapy Sales and Revenue in Global (2017-2022)
7.11.5 Takeda Key News
7.12 Ferring
7.12.1 Ferring Corporate Summary
7.12.2 Ferring Peptide Therapy Business Overview
7.12.3 Ferring Peptide Therapy Major Product Offerings
7.12.4 Ferring Peptide Therapy Sales and Revenue in Global (2017-2022)
7.12.5 Ferring Key News
7.13 AbbVie
7.13.1 AbbVie Corporate Summary
7.13.2 AbbVie Peptide Therapy Business Overview
7.13.3 AbbVie Peptide Therapy Major Product Offerings
7.13.4 AbbVie Peptide Therapy Sales and Revenue in Global (2017-2022)
7.13.5 AbbVie Key News
7.14 Heinis
7.14.1 Heinis Corporate Summary
7.14.2 Heinis Business Overview
7.14.3 Heinis Peptide Therapy Major Product Offerings
7.14.4 Heinis Peptide Therapy Sales and Revenue in Global (2017-2022)
7.14.5 Heinis Key News
7.15 Hemmo
7.15.1 Hemmo Corporate Summary
7.15.2 Hemmo Business Overview
7.15.3 Hemmo Peptide Therapy Major Product Offerings
7.15.4 Hemmo Peptide Therapy Sales and Revenue in Global (2017-2022)
7.15.5 Hemmo Key News
7.16 Emcure Pharmaceutical
7.16.1 Emcure Pharmaceutical Corporate Summary
7.16.2 Emcure Pharmaceutical Business Overview
7.16.3 Emcure Pharmaceutical Peptide Therapy Major Product Offerings
7.16.4 Emcure Pharmaceutical Peptide Therapy Sales and Revenue in Global (2017-2022)
7.16.5 Emcure Pharmaceutical Key News
7.17 Cipla
7.17.1 Cipla Corporate Summary
7.17.2 Cipla Business Overview
7.17.3 Cipla Peptide Therapy Major Product Offerings
7.17.4 Cipla Peptide Therapy Sales and Revenue in Global (2017-2022)
7.17.5 Cipla Key News
7.18 Gland Pharma
7.18.1 Gland Pharma Corporate Summary
7.18.2 Gland Pharma Business Overview
7.18.3 Gland Pharma Peptide Therapy Major Product Offerings
7.18.4 Gland Pharma Peptide Therapy Sales and Revenue in Global (2017-2022)
7.18.5 Gland Pharma Key News
7.19 Troikaa Pharmaceuticals
7.19.1 Troikaa Pharmaceuticals Corporate Summary
7.19.2 Troikaa Pharmaceuticals Business Overview
7.19.3 Troikaa Pharmaceuticals Peptide Therapy Major Product Offerings
7.19.4 Troikaa Pharmaceuticals Peptide Therapy Sales and Revenue in Global (2017-2022)
7.19.5 Troikaa Pharmaceuticals Key News
7.20 Biological E
7.20.1 Biological E Corporate Summary
7.20.2 Biological E Business Overview
7.20.3 Biological E Peptide Therapy Major Product Offerings
7.20.4 Biological E Peptide Therapy Sales and Revenue in Global (2017-2022)
7.20.5 Biological E Key News
8 GLOBAL PEPTIDE THERAPY PRODUCTION CAPACITY, ANALYSIS
8.1 Global Peptide Therapy Production Capacity, 2017-2028
8.2 Peptide Therapy Production Capacity of Key Manufacturers in Global Market
8.3 Global Peptide Therapy Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 PEPTIDE THERAPY SUPPLY CHAIN ANALYSIS
10.1 Peptide Therapy Industry Value Chain
10.2 Peptide Therapy Upstream Market
10.3 Peptide Therapy Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Peptide Therapy Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES
Table 1. Key Players of Peptide Therapy in Global Market
Table 2. Top Peptide Therapy Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Peptide Therapy Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Peptide Therapy Revenue Share by Companies, 2017-2022
Table 5. Global Peptide Therapy Sales by Companies, (K Units), 2017-2022
Table 6. Global Peptide Therapy Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Peptide Therapy Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers Peptide Therapy Product Type
Table 9. List of Global Tier 1 Peptide Therapy Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Peptide Therapy Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Peptide Therapy Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Peptide Therapy Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Peptide Therapy Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Peptide Therapy Sales (K Units), 2017-2022
Table 15. By Type - Global Peptide Therapy Sales (K Units), 2023-2028
Table 16. By Application – Global Peptide Therapy Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Peptide Therapy Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Peptide Therapy Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Peptide Therapy Sales (K Units), 2017-2022
Table 20. By Application - Global Peptide Therapy Sales (K Units), 2023-2028
Table 21. By Region – Global Peptide Therapy Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Peptide Therapy Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Peptide Therapy Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Peptide Therapy Sales (K Units), 2017-2022
Table 25. By Region - Global Peptide Therapy Sales (K Units), 2023-2028
Table 26. By Country - North America Peptide Therapy Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Peptide Therapy Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Peptide Therapy Sales, (K Units), 2017-2022
Table 29. By Country - North America Peptide Therapy Sales, (K Units), 2023-2028
Table 30. By Country - Europe Peptide Therapy Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Peptide Therapy Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Peptide Therapy Sales, (K Units), 2017-2022
Table 33. By Country - Europe Peptide Therapy Sales, (K Units), 2023-2028
Table 34. By Region - Asia Peptide Therapy Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Peptide Therapy Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Peptide Therapy Sales, (K Units), 2017-2022
Table 37. By Region - Asia Peptide Therapy Sales, (K Units), 2023-2028
Table 38. By Country - South America Peptide Therapy Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Peptide Therapy Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Peptide Therapy Sales, (K Units), 2017-2022
Table 41. By Country - South America Peptide Therapy Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Peptide Therapy Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Peptide Therapy Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Peptide Therapy Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Peptide Therapy Sales, (K Units), 2023-2028
Table 46. Eli Lilly Corporate Summary
Table 47. Eli Lilly Peptide Therapy Product Offerings
Table 48. Eli Lilly Peptide Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. AstraZeneca Corporate Summary
Table 50. AstraZeneca Peptide Therapy Product Offerings
Table 51. AstraZeneca Peptide Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. Merck Corporate Summary
Table 53. Merck Peptide Therapy Product Offerings
Table 54. Merck Peptide Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. Ipsen Corporate Summary
Table 56. Ipsen Peptide Therapy Product Offerings
Table 57. Ipsen Peptide Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 58. Novo Nordisk Corporate Summary
Table 59. Novo Nordisk Peptide Therapy Product Offerings
Table 60. Novo Nordisk Peptide Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 61. Teva Pharmaceutical Industries Corporate Summary
Table 62. Teva Pharmaceutical Industries Peptide Therapy Product Offerings
Table 63. Teva Pharmaceutical Industries Peptide Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 64. Abbott Laboratories Corporate Summary
Table 65. Abbott Laboratories Peptide Therapy Product Offerings
Table 66. Abbott Laboratories Peptide Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 67. Sanofi Corporate Summary
Table 68. Sanofi Peptide Therapy Product Offerings
Table 69. Sanofi Peptide Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 70. J & J Corporate Summary
Table 71. J & J Peptide Therapy Product Offerings
Table 72. J & J Peptide Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 73. Novartis Corporate Summary
Table 74. Novartis Peptide Therapy Product Offerings
Table 75. Novartis Peptide Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 76. Takeda Corporate Summary
Table 77. Takeda Peptide Therapy Product Offerings
Table 78. Takeda Peptide Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 79. Ferring Corporate Summary
Table 80. Ferring Peptide Therapy Product Offerings
Table 81. Ferring Peptide Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 82. AbbVie Corporate Summary
Table 83. AbbVie Peptide Therapy Product Offerings
Table 84. AbbVie Peptide Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 85. Heinis Corporate Summary
Table 86. Heinis Peptide Therapy Product Offerings
Table 87. Heinis Peptide Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 88. Hemmo Corporate Summary
Table 89. Hemmo Peptide Therapy Product Offerings
Table 90. Hemmo Peptide Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 91. Emcure Pharmaceutical Corporate Summary
Table 92. Emcure Pharmaceutical Peptide Therapy Product Offerings
Table 93. Emcure Pharmaceutical Peptide Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 94. Cipla Corporate Summary
Table 95. Cipla Peptide Therapy Product Offerings
Table 96. Cipla Peptide Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 97. Gland Pharma Corporate Summary
Table 98. Gland Pharma Peptide Therapy Product Offerings
Table 99. Gland Pharma Peptide Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 100. Troikaa Pharmaceuticals Corporate Summary
Table 101. Troikaa Pharmaceuticals Peptide Therapy Product Offerings
Table 102. Troikaa Pharmaceuticals Peptide Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 103. Biological E Corporate Summary
Table 104. Biological E Peptide Therapy Product Offerings
Table 105. Biological E Peptide Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 106. Peptide Therapy Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 107. Global Peptide Therapy Capacity Market Share of Key Manufacturers, 2020-2022
Table 108. Global Peptide Therapy Production by Region, 2017-2022 (K Units)
Table 109. Global Peptide Therapy Production by Region, 2023-2028 (K Units)
Table 110. Peptide Therapy Market Opportunities & Trends in Global Market
Table 111. Peptide Therapy Market Drivers in Global Market
Table 112. Peptide Therapy Market Restraints in Global Market
Table 113. Peptide Therapy Raw Materials
Table 114. Peptide Therapy Raw Materials Suppliers in Global Market
Table 115. Typical Peptide Therapy Downstream
Table 116. Peptide Therapy Downstream Clients in Global Market
Table 117. Peptide Therapy Distributors and Sales Agents in Global Market
Table 1. Key Players of Peptide Therapy in Global Market
Table 2. Top Peptide Therapy Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Peptide Therapy Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Peptide Therapy Revenue Share by Companies, 2017-2022
Table 5. Global Peptide Therapy Sales by Companies, (K Units), 2017-2022
Table 6. Global Peptide Therapy Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Peptide Therapy Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers Peptide Therapy Product Type
Table 9. List of Global Tier 1 Peptide Therapy Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Peptide Therapy Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Peptide Therapy Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Peptide Therapy Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Peptide Therapy Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Peptide Therapy Sales (K Units), 2017-2022
Table 15. By Type - Global Peptide Therapy Sales (K Units), 2023-2028
Table 16. By Application – Global Peptide Therapy Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Peptide Therapy Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Peptide Therapy Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Peptide Therapy Sales (K Units), 2017-2022
Table 20. By Application - Global Peptide Therapy Sales (K Units), 2023-2028
Table 21. By Region – Global Peptide Therapy Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Peptide Therapy Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Peptide Therapy Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Peptide Therapy Sales (K Units), 2017-2022
Table 25. By Region - Global Peptide Therapy Sales (K Units), 2023-2028
Table 26. By Country - North America Peptide Therapy Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Peptide Therapy Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Peptide Therapy Sales, (K Units), 2017-2022
Table 29. By Country - North America Peptide Therapy Sales, (K Units), 2023-2028
Table 30. By Country - Europe Peptide Therapy Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Peptide Therapy Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Peptide Therapy Sales, (K Units), 2017-2022
Table 33. By Country - Europe Peptide Therapy Sales, (K Units), 2023-2028
Table 34. By Region - Asia Peptide Therapy Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Peptide Therapy Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Peptide Therapy Sales, (K Units), 2017-2022
Table 37. By Region - Asia Peptide Therapy Sales, (K Units), 2023-2028
Table 38. By Country - South America Peptide Therapy Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Peptide Therapy Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Peptide Therapy Sales, (K Units), 2017-2022
Table 41. By Country - South America Peptide Therapy Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Peptide Therapy Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Peptide Therapy Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Peptide Therapy Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Peptide Therapy Sales, (K Units), 2023-2028
Table 46. Eli Lilly Corporate Summary
Table 47. Eli Lilly Peptide Therapy Product Offerings
Table 48. Eli Lilly Peptide Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. AstraZeneca Corporate Summary
Table 50. AstraZeneca Peptide Therapy Product Offerings
Table 51. AstraZeneca Peptide Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. Merck Corporate Summary
Table 53. Merck Peptide Therapy Product Offerings
Table 54. Merck Peptide Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. Ipsen Corporate Summary
Table 56. Ipsen Peptide Therapy Product Offerings
Table 57. Ipsen Peptide Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 58. Novo Nordisk Corporate Summary
Table 59. Novo Nordisk Peptide Therapy Product Offerings
Table 60. Novo Nordisk Peptide Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 61. Teva Pharmaceutical Industries Corporate Summary
Table 62. Teva Pharmaceutical Industries Peptide Therapy Product Offerings
Table 63. Teva Pharmaceutical Industries Peptide Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 64. Abbott Laboratories Corporate Summary
Table 65. Abbott Laboratories Peptide Therapy Product Offerings
Table 66. Abbott Laboratories Peptide Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 67. Sanofi Corporate Summary
Table 68. Sanofi Peptide Therapy Product Offerings
Table 69. Sanofi Peptide Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 70. J & J Corporate Summary
Table 71. J & J Peptide Therapy Product Offerings
Table 72. J & J Peptide Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 73. Novartis Corporate Summary
Table 74. Novartis Peptide Therapy Product Offerings
Table 75. Novartis Peptide Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 76. Takeda Corporate Summary
Table 77. Takeda Peptide Therapy Product Offerings
Table 78. Takeda Peptide Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 79. Ferring Corporate Summary
Table 80. Ferring Peptide Therapy Product Offerings
Table 81. Ferring Peptide Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 82. AbbVie Corporate Summary
Table 83. AbbVie Peptide Therapy Product Offerings
Table 84. AbbVie Peptide Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 85. Heinis Corporate Summary
Table 86. Heinis Peptide Therapy Product Offerings
Table 87. Heinis Peptide Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 88. Hemmo Corporate Summary
Table 89. Hemmo Peptide Therapy Product Offerings
Table 90. Hemmo Peptide Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 91. Emcure Pharmaceutical Corporate Summary
Table 92. Emcure Pharmaceutical Peptide Therapy Product Offerings
Table 93. Emcure Pharmaceutical Peptide Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 94. Cipla Corporate Summary
Table 95. Cipla Peptide Therapy Product Offerings
Table 96. Cipla Peptide Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 97. Gland Pharma Corporate Summary
Table 98. Gland Pharma Peptide Therapy Product Offerings
Table 99. Gland Pharma Peptide Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 100. Troikaa Pharmaceuticals Corporate Summary
Table 101. Troikaa Pharmaceuticals Peptide Therapy Product Offerings
Table 102. Troikaa Pharmaceuticals Peptide Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 103. Biological E Corporate Summary
Table 104. Biological E Peptide Therapy Product Offerings
Table 105. Biological E Peptide Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 106. Peptide Therapy Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 107. Global Peptide Therapy Capacity Market Share of Key Manufacturers, 2020-2022
Table 108. Global Peptide Therapy Production by Region, 2017-2022 (K Units)
Table 109. Global Peptide Therapy Production by Region, 2023-2028 (K Units)
Table 110. Peptide Therapy Market Opportunities & Trends in Global Market
Table 111. Peptide Therapy Market Drivers in Global Market
Table 112. Peptide Therapy Market Restraints in Global Market
Table 113. Peptide Therapy Raw Materials
Table 114. Peptide Therapy Raw Materials Suppliers in Global Market
Table 115. Typical Peptide Therapy Downstream
Table 116. Peptide Therapy Downstream Clients in Global Market
Table 117. Peptide Therapy Distributors and Sales Agents in Global Market
LIST OF FIGURES
Figure 1. Peptide Therapy Segment by Type
Figure 2. Peptide Therapy Segment by Application
Figure 3. Global Peptide Therapy Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Peptide Therapy Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Peptide Therapy Revenue, 2017-2028 (US$, Mn)
Figure 7. Peptide Therapy Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Peptide Therapy Revenue in 2021
Figure 9. By Type - Global Peptide Therapy Sales Market Share, 2017-2028
Figure 10. By Type - Global Peptide Therapy Revenue Market Share, 2017-2028
Figure 11. By Type - Global Peptide Therapy Price (US$/Unit), 2017-2028
Figure 12. By Application - Global Peptide Therapy Sales Market Share, 2017-2028
Figure 13. By Application - Global Peptide Therapy Revenue Market Share, 2017-2028
Figure 14. By Application - Global Peptide Therapy Price (US$/Unit), 2017-2028
Figure 15. By Region - Global Peptide Therapy Sales Market Share, 2017-2028
Figure 16. By Region - Global Peptide Therapy Revenue Market Share, 2017-2028
Figure 17. By Country - North America Peptide Therapy Revenue Market Share, 2017-2028
Figure 18. By Country - North America Peptide Therapy Sales Market Share, 2017-2028
Figure 19. US Peptide Therapy Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Peptide Therapy Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Peptide Therapy Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Peptide Therapy Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Peptide Therapy Sales Market Share, 2017-2028
Figure 24. Germany Peptide Therapy Revenue, (US$, Mn), 2017-2028
Figure 25. France Peptide Therapy Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Peptide Therapy Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Peptide Therapy Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Peptide Therapy Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Peptide Therapy Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Peptide Therapy Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Peptide Therapy Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Peptide Therapy Sales Market Share, 2017-2028
Figure 33. China Peptide Therapy Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Peptide Therapy Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Peptide Therapy Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Peptide Therapy Revenue, (US$, Mn), 2017-2028
Figure 37. India Peptide Therapy Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Peptide Therapy Revenue Market Share, 2017-2028
Figure 39. By Country - South America Peptide Therapy Sales Market Share, 2017-2028
Figure 40. Brazil Peptide Therapy Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Peptide Therapy Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Peptide Therapy Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Peptide Therapy Sales Market Share, 2017-2028
Figure 44. Turkey Peptide Therapy Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Peptide Therapy Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Peptide Therapy Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Peptide Therapy Revenue, (US$, Mn), 2017-2028
Figure 48. Global Peptide Therapy Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Peptide Therapy by Region, 2021 VS 2028
Figure 50. Peptide Therapy Industry Value Chain
Figure 51. Marketing Channels
Figure 1. Peptide Therapy Segment by Type
Figure 2. Peptide Therapy Segment by Application
Figure 3. Global Peptide Therapy Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Peptide Therapy Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Peptide Therapy Revenue, 2017-2028 (US$, Mn)
Figure 7. Peptide Therapy Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Peptide Therapy Revenue in 2021
Figure 9. By Type - Global Peptide Therapy Sales Market Share, 2017-2028
Figure 10. By Type - Global Peptide Therapy Revenue Market Share, 2017-2028
Figure 11. By Type - Global Peptide Therapy Price (US$/Unit), 2017-2028
Figure 12. By Application - Global Peptide Therapy Sales Market Share, 2017-2028
Figure 13. By Application - Global Peptide Therapy Revenue Market Share, 2017-2028
Figure 14. By Application - Global Peptide Therapy Price (US$/Unit), 2017-2028
Figure 15. By Region - Global Peptide Therapy Sales Market Share, 2017-2028
Figure 16. By Region - Global Peptide Therapy Revenue Market Share, 2017-2028
Figure 17. By Country - North America Peptide Therapy Revenue Market Share, 2017-2028
Figure 18. By Country - North America Peptide Therapy Sales Market Share, 2017-2028
Figure 19. US Peptide Therapy Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Peptide Therapy Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Peptide Therapy Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Peptide Therapy Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Peptide Therapy Sales Market Share, 2017-2028
Figure 24. Germany Peptide Therapy Revenue, (US$, Mn), 2017-2028
Figure 25. France Peptide Therapy Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Peptide Therapy Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Peptide Therapy Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Peptide Therapy Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Peptide Therapy Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Peptide Therapy Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Peptide Therapy Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Peptide Therapy Sales Market Share, 2017-2028
Figure 33. China Peptide Therapy Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Peptide Therapy Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Peptide Therapy Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Peptide Therapy Revenue, (US$, Mn), 2017-2028
Figure 37. India Peptide Therapy Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Peptide Therapy Revenue Market Share, 2017-2028
Figure 39. By Country - South America Peptide Therapy Sales Market Share, 2017-2028
Figure 40. Brazil Peptide Therapy Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Peptide Therapy Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Peptide Therapy Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Peptide Therapy Sales Market Share, 2017-2028
Figure 44. Turkey Peptide Therapy Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Peptide Therapy Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Peptide Therapy Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Peptide Therapy Revenue, (US$, Mn), 2017-2028
Figure 48. Global Peptide Therapy Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Peptide Therapy by Region, 2021 VS 2028
Figure 50. Peptide Therapy Industry Value Chain
Figure 51. Marketing Channels
